Form 8-K - Current report:
SEC Accession No. 0001193125-24-274894
Filing Date
2024-12-11
Accepted
2024-12-11 08:25:50
Documents
2
Period of Report
2024-12-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d825014d8k.htm 8-K 19739
2 EX-99.1 d825014dex991.htm EX-99.1 10191
  Complete submission text file 0001193125-24-274894.txt   31089
Mailing Address 333 SOUTH GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH GRAND AVENUE, 28TH FLOOR LOS ANGELES CA 90071 213-830-6300
Oaktree Acquisition Corp. III Life Sciences (Filer) CIK: 0002029769 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42383 | Film No.: 241540246
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)